TRIB Share Price

Open 4.83 Change Price %
High 5.11 1 Day 0.26 5.44
Low 4.80 1 Week 0.00 0.00
Close 5.04 1 Month -0.22 -4.18
Volume 109461 1 Year -1.73 -25.55
52 Week High 7.40
52 Week Low 4.22
TRIB Important Levels
Resistance 2 5.33
Resistance 1 5.21
Pivot 4.98
Support 1 4.87
Support 2 4.75
NASDAQ USA Most Active Stocks
YHOO 52.58 0.00%
YHOO 52.58 0.00%
YHOO 52.58 0.00%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
MU 44.31 6.39%
MU 44.31 6.39%
MU 44.31 6.39%
RIMM 13.03 0.39%
More..
NASDAQ USA Top Gainers Stocks
LOCM 0.09 50.00%
SCHS 0.04 33.33%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
HLIT 3.70 25.42%
OTT 2.39 25.13%
QNST 8.90 20.76%
VRTA 4.00 19.40%
SNSS 2.56 19.07%
GCFB 0.44 18.92%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
GMETP 0.15 -76.92%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
More..

Trinity Biotech plc (NASDAQ: TRIB)

TRIB Technical Analysis 3
As on 31st Oct 2017 TRIB Share Price closed @ 5.04 and we RECOMMEND Sell for LONG-TERM with Stoploss of 5.87 & Sell for SHORT-TERM with Stoploss of 5.29 we also expect STOCK to react on Following IMPORTANT LEVELS.
TRIB Target for November
1st Target up-side 5.8
2nd Target up-side 6.34
3rd Target up-side 6.87
1st Target down-side 4.28
2nd Target down-side 3.74
3rd Target down-side 3.21
TRIB Other Details
Segment EQ
Market Capital 303439360.00
Sector Healthcare
Industry Diagnostic Substances
Offical website http://www.trinitybiotech.com
TRIB Address
TRIB
IDA Business Park
Bray,
Ireland
Phone: 353 1 276 9800
Fax: 353 1 276 9888
TRIB Latest News
Interactive Technical Analysis Chart Trinity Biotech plc ( TRIB NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Trinity Biotech plc
TRIB Business Profile
Trinity Biotech plc (Trinity Biotech)develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. These products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the liver and intestine. The Company is a provider of raw materials to the life sciences industry and research institutes globally through the Company subsidiary, Fitzgerald Industries. It markets its portfolio of over 275 products to customers in 75 countries around the world. It markets its products in the United States through a direct sales force and in the rest of the world through a combination of direct selling and a network of distributors. On July 26, 2013, it acquired Immco Diagnostics Inc.